HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$8.66
Day range
$8.23 - $8.66
Year range
$6.42 - $29.60
Market cap
457.64M USD
Avg Volume
377.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.74M | 16.03% |
Net income | -25.57M | -12.01% |
Net profit margin | — | — |
Earnings per share | -0.43 | 18.87% |
EBITDA | -29.60M | -15.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 341.44M | 67.81% |
Total assets | 363.56M | 60.97% |
Total liabilities | 20.41M | -5.50% |
Total equity | 343.15M | — |
Shares outstanding | 53.09M | — |
Price to book | 1.28 | — |
Return on assets | -19.99% | — |
Return on capital | -20.71% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -25.57M | -12.01% |
Cash from operations | -19.59M | -44.77% |
Cash from investing | 6.96M | 104.82% |
Cash from financing | 706.00K | 117.90% |
Net change in cash | -11.93M | 92.43% |
Free cash flow | -10.08M | -54.99% |
About
Founded
2018
Headquarters
Website
Employees
60
